UK-based biopharmaceutical company, PhoreMost, is to deploy its in-house expertise and next-generation phenotypic screening platform, SITESEEKER, toward disease-relevant pathways nominated by Roche.
Dow Chemical has teamed up with Germany's greenovation Biotech to
develop ways of manufacturing therapeutic proteins such as
monoclonal antibodies in plants.
France's BioProtein Technologies, a biotechnology company
specialising in the production of therapeutic proteins in the milk
of transgenic rabbits, has extended its biomanufacturing services
to include recombinant vaccine production.
Engineers in the US are one step closer to mass-producing
therapeutic proteins needed by today's pharmaceutical industry.
Researchers claim to have achieved a major milestone in their
efforts to effectively produce human therapeutics...